We inspected publicly available resources in order to compare the expression levels of each paralog in cancer tissues in human and, in agreement with previous data [17], we found an overall overexpression of POTE paralogs belonging to groups II, III, and IV in cancer, and more specifically, in breast cancer and esophageal adenocarcinoma. This evidence concerns the gene POTED and breast cancer.